Genethon SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genethon SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH143005D
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Genethon SA (Genethon) is a non-profit biotherapy research and development organization which designs and develops gene therapy products for rare diseases. The company is developing gene therapy products for the treatment of limb girdle myophaties, duchenne muscular dystrophy, myotubular myopathy, spinal muscular atrophy, and huntington's disease among others. Genethon conducts research programs, investments in technological innovation, pre-clinical assessment platforms, bio-production, quality control, translational development, research up to clinical validation, and biomanufacturing services. The organization is developing medicines for rare neuromuscular diseases, liver diseases, blood and eye disorders. It works in collaboration with other research institutes such as Children's Hospital, Boston Great Ormond Street Hospital for clinical immunodeficiency developments. The organization is funded by Association Francaise contre les Myopathies(AFM-Telethon). Genethon is headquartered in Paris, France.

Genethon SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Genethon SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genethon SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genethon SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genethon SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Genethon SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Genethon SA, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

AveXis Enters into Licensing Agreement with Genethon and Centre National de la Recherche Scientifique 10

Orchard Therapeutics Enters into Agreement with Genethon 11

Sarepta Therapeutics Enters into Research Agreement with Genethon 12

Genethon and CRISPR Therapeutics Enter into Research Agreement 13

NanoMedSyn Enters into Agreement with Genethon 14

Selecta Biosciences Enters into Research Agreement with Genethon 15

Audentes Therapeutics Enters Into Co-Development Agreement With Genethon For AT001 16

GenSight Biologics Enters into Agreement with Genethon 17

Licensing Agreements 19

Spark Therapeutics Enters into Licensing Agreement with Genethon 19

Miltenyi Biotec Enters into Licensing Agreement with Genethon 20

GenSight Biologics Enters into Licensing Agreement with AFM, Genethon and Inserm Transfert 21

CEVEC Pharma Enters into Licensing Agreement with Genethon 23

Genethon SA - Key Employees 24

Genethon SA - Locations And Subsidiaries 25

Head Office 25

Recent Developments 26

Product News 26

Sep 26, 2017: Dynacure joins ongoing Natural History Study in Centronuclear Myopathies with the Institute of Myology (France) 26

07/27/2017: Sarepta Therapeutics Announces its Partner, Genethon, Published New Micro-Dystrophin Gene Therapy Data in Nature Communications 27

Jul 25, 2017: Microdystrophin restores muscle strength in Duchenne muscular dystrophy 28

Apr 17, 2017: New step towards the treatment of myotubular myopathy: gene therapy restores strength and prolongs lives in affected dogs 29

03/24/2017: Action Duchenne Funding Gene Therapy to Advance Treatments for Duchenne 30

Jan 26, 2017: Gene therapy for Pompe disease effective in mice, poised for human trials 31

Jan 11, 2018: Genethon welcomes interim data of a phase I / II clinical trial with a gene therapy product developed in its laboratories 33

Clinical Trials 34

Jul 25, 2017: Microdystrophin restores muscle strength in Duchenne muscular dystrophy 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

Genethon SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Genethon SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Genethon SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Genethon SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Genethon SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genethon SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Genethon SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genethon SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

Genethon SA, Pharmaceuticals & Healthcare, Key Facts 2

Genethon SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genethon SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genethon SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genethon SA, Deals By Therapy Area, 2012 to YTD 2018 8

Genethon SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

AveXis Enters into Licensing Agreement with Genethon and Centre National de la Recherche Scientifique 10

Orchard Therapeutics Enters into Agreement with Genethon 11

Sarepta Therapeutics Enters into Research Agreement with Genethon 12

Genethon and CRISPR Therapeutics Enter into Research Agreement 13

NanoMedSyn Enters into Agreement with Genethon 14

Selecta Biosciences Enters into Research Agreement with Genethon 15

Audentes Therapeutics Enters Into Co-Development Agreement With Genethon For AT001 16

GenSight Biologics Enters into Agreement with Genethon 17

Spark Therapeutics Enters into Licensing Agreement with Genethon 19

Miltenyi Biotec Enters into Licensing Agreement with Genethon 20

GenSight Biologics Enters into Licensing Agreement with AFM, Genethon and Inserm Transfert 21

CEVEC Pharma Enters into Licensing Agreement with Genethon 23

Genethon SA, Key Employees 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Genethon SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 17970
Site License
USD 500 INR 35940
Corporate User License
USD 750 INR 53910

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com